Dayly España

download Dayly España

of 5

Transcript of Dayly España

  • 8/2/2019 Dayly Espaa

    1/5

    Spain TodayToday's best ideas in Spanish Equities

    Friday, April 27, 2012

    Disclosures are available on www.cheuvreux.com

    Upcoming Conferences

    General news

    www.cheuvreux.com

    For further info on the events below:[email protected] your usual CA Cheuvreux contact.Spain - Sovereign rating hammered two notches by S&P

    , +34 91 495 16 29)Iigo Vega, Research Analyst ([email protected] 21-23 May : Pan-Europe Forum (London)19-21 September :Autumn Conference(Paris)

    Company updates Upcoming corporate Roadshows overnext 2 weeks

    Antena 3 3/Underperform TP EUR4 (+1%) For further info on the events below:Highlights from conference call [email protected]

    or your usual CA Cheuvreux contact.Adrian Zunzunegui, Head of Research ([email protected], 34 91 495 16 28)

    02 May : Skandinaviska Enskilda Banken(England, Uk)Ebro Foods- 1/Selected List TP EUR17 (+27%)

    Sells Nomen for EUR30.1m 03 May : Seche Environnement (England,Uk)Iigo Egusquiza, Research Analyst ([email protected], +34 91 495 16 33)08 May : Lvmh (United States)08 May : Stora Enso (United States)Ence 2/Outperform TP EUR2.3 (+38%)08 May : Total Sa (United States)

    Good Q1 results, very positive message - BUY 09 May : Rautaruukki (England, Uk)Adrian Zunzunegui, Head of Research ([email protected], 34 91 495 16 28) 09 May : Sanoma (England, Uk)

    10 May : Ericsson Telecom Ab (England, Uk)10 May : Sodexo (England, Uk)Gas Natural (n/r)11 May : Ericsson Telecom Ab (France)

    Noise on a possible merger with Repsol

    Jos Porta, Sector Head , +34 91 495 16 71)([email protected]

    Viscofan - 3/Underperform - TP EUR34.7 (+1%)

    Q1-12 results overall in line

    Iigo Egusquiza, Research Analyst ([email protected], +34 91 495 16 33)

  • 8/2/2019 Dayly Espaa

    2/5

    Spain TodayFriday, 27 April 2012

    General newsSpain- Sovereign rating hammered two notches by S&PIigo Vega, Research Analyst ([email protected], +34 91 495 16 29)

    S&P has cut Spain's credit rating from A to BBB+ with a negative outlook. The report mentions the likely inability to meet

    budget deficit targets (they estimate -6.2% in 2012 and -4.4% in 2013) in a context of private deleveraging and GDP

    contraction (-1.5% in 2012 and -0.3% in 2013). S&P believes that the delay in adopting the 2012 budget will make targets

    more challenging. Following almost EUR90bn capital outflows over Mar-11-Jan12 (and we still need to add those in Feb-

    Apr of this year- not disclosed yet), the downgrade will hardly be a surprise to many investors. But it represents a threat

    to the new government's plan A, which was based on taking the hard measures and gradually gaining credibility on the

    back of these steps. This is clearly not happening (the market is not now a great believer in orthodox deleveraging and

    austerity yielding results). Let's see what plan B is. Also, it will be interesting to see the reaction of some of the Spanish

    banks playing the carry trade, although we do not expect any changes to regulatory capital consumption of holdingSpanish sovereign debt (only in CCPs haircuts could rise further, but the usage of CCPs has came down as a result of

    LTROs.).

    Company updates

    Antena 3 3/Underperform TP EUR4 (+1%) Highlights from conference callAdrian Zunzunegui, Research Analyst ([email protected], +34 91 495 16 28)

    Antena 3 Q1 results came out slightly better than expected (EUR14.1m EBITDA vs. our EUR10m estimate, consensus at

    EUR11m) as A3TV is doing better than TL5 in terms of revenue share, which allows them a pricing premium (c/GRP down

    just 11% in Q1, when the average market price is down more than 15%, and revenue share at 34.3% in Q1 are obviously

    the net positives). We nevertheless believe this is not enough within such a weak TV ad market, and opex management

    will increasingly become the name of the game further into the year. A3TV opex is down just 1.5% despite top-line

    declines of c.a. 9% y-o-y, hence the EBITDA margin stands at 7.5%. TL5 will deliver a far weaker top line (lower share,

    weaker prices) but better opex, which will result in a higher EBITDA margin.

    In overall terms, the message from management at A3TV's conference call was a cautious one. According to A3TV

    management, it is now clear that Spain's TV ad spending will come down by between 7% and 10% a (us at -10%, we

    feel that, if anything, there is still downside risk to our number). Q2 has started weaker than Q1 (according to

    management April is worse than Q1, despite an easing comp base, and there is no visibility at all on May, though due to a

    better comparison base A3TV's CEO believes it should be less bad than the first four months of the year). We believe

    May might be again down by double digits, and the outlook on June (the EuroCup is seen as this year's last hope) is less

    and less clear.

    Furthermore, our belief (contrary to management) is that the 34% revenue share is not easily sustainable (we got the

    feeling that in April TL5 is doing better in terms of revenue share, hence A3TV is no longer taking all the share lost by

    regional TVs and smaller DTT players). Pricing pressure keeps hitting new highs (average market prices in April are down

    by more than 20% y-o-y...). In other words, new cuts to the top line are to come (at least -10% for the FY market), the

    share will not be as good, and pricing pressure is on the rise. In the medium term we see no room for improvement from

    here, and the recent relative outperformance of A3TV to TL5, though justified, is hard to sustain.

    Highlights:

    TV ad market: according to the company, it is very difficult to know what is going to happen in the ad marketover the full year. Q1-12 was weak and April was in line (or slightly weaker) with the first quarter. Even though

    there is no visibility, they do not expect FY-12 to be as bad as Q1 and they find it difficult to believe that the FY

    market could fall by as much as the 18% annual decline seen YTD. In their view, a more reasonable estimate for

    the FY could be a drop of 7-10%. We are at -10%, and believe that May/June may again disappoint.

    Revenue share: they expect their revenue share to stand at c.a. 43-44% in FY-12E (following the merger with LaSexta, which they expect the anti-trust authority to approve by June). There could be some commercial changesat La Sexta (cheaper than CUATRO but with similar profiles). We believe the 34% share of A3TV standalone is

    not easy to sustain

    2 www.cheuvreux.com

  • 8/2/2019 Dayly Espaa

    3/5

    Spain TodayFriday, 27 April 2012

    Audience share: There is no limit, and with good programming there is room for growth (we would say, at whatcost?). What A3TV is not going to do is change its policy in order to compete with the Euro Cup.

    Opex should grow due to Formula One TV rights. Working capital: Negative working capital in Q1-12 because of the Formula One rights (two payments, the first

    being in March) and the acquisition of treasury stock (7% in accordance with the merger agreement).

    Net debt could stand at around EUR220m-240m after the merger. We look for EUR250m net debt by 2012E.Ebro Foods- 1/Selected List TP EUR17 (+27%) Sells Nomen for EUR30.1mIigo Egusquiza, Research Analyst ( , +34 91 495 16 33)[email protected]

    Ebro Foods has just sent a statement to the Spanish National Securities Market Commission (CNMV) confirming that they

    have reached an agreement with the Catalan group Arrossaires for the sale of the rice brand Nomen for EUR30.1m. The

    operation consists of an initial payment of EUR1.5m plus 13 annual payments of EUR2.9m, so the final price including

    deferred interest will be EUR39.2m, which is in line with expectations. The agreement is pending the authorisation of the

    Spanish competition authorities (expected in September 2012).Ebro acquired SOS Rice from Deoleo for EUR195m and the Spanish competition authorities forced Ebro to sell some of

    the rice brands under SOS Rice, including Nomen.

    We see this agreement as good news for Ebro as it would represent a reduction in the price paid by Ebro for SOS Rice

    and it would also bring down debt, which is already very limited.

    Ence 2/Outperform TP EUR2.3 (+38%) Good Q1 results, very positive message - BUYAdrian Zunzunegui, Research Analyst ([email protected], +34 91 495 16 28)

    Ence's Q1 results came out yesterday in line with expectations at both the top-line and EBITDA levels. We nevertheless

    read positively q-o-q trends, since volumes are starting to perform and price increases implemented in recent months

    should start feeding in as of Q2. This, coupled with good cash costs, suggests a very positive outlook for the next few

    months. Operating profits should show increased growth in the upcoming quarters, and our FY EBITDA estimate of

    EUR147m now seems easy to achieve (estimates risk on the upside).

    Management stated at the AGM they plan to raise the dividend payment over the medium-term. The company plans to

    raise EUR300m via divestments, 50% of these funds to be handed back to shareholders via a dividend over the next

    three years. This amounts to 35% of Ence's current market cap (and comes on top of the current ordinary dividend). This

    plan is to be funded through the sale of its forestry assets, starting with those in Uruguay (that have a EUR50m BV, and

    could be sold for between EUR75m and EUR100m (apparently, there are 20 interested parties), or between 1.5x and 2x

    BV, Ence is now trading at 0.6x P/BV), followed by other forestry assets in 2013/14. The company also plans to buy own

    shares (from the current 5% to the 10% legal maximum, an estimated impact of EUR20m at current prices), which might

    come from the stake hold by troubled "caja" Liberbank.

    We reiterate our very positive view on Ence: the stock trades at 0.6 P/BV, when volumes and pricing indicate it should be

    trading at least at a through-the-cycle average of 0.8x / 0.9x (and on top of this cash costs are doing slightly better). Our

    target price of EUR2.30 offers more than 40% upside from current prices. The raised dividend is also very positive news,

    and once they start to deliver it will be seen that trading at a 40% discount to BV makes no sense.

    Q1 highlights:

    Consolidated sales came down by 8% y-o-y to EUR201.5m (fully in line with street expectations of EUR201.1m), a 2%

    increase from Q4. Pulp sales dropped by 10% to EUR143.1m, +2% on the previous quarter on good volumes (+7% y-o-

    y) and better utilisation ratios of 97%. The impact of price increases is to come next: another USD40/t price hike is

    expected as of May. Electricity sales +17% to EUR50.1m (above expectations on better than anticipated pricing, +12%,

    and an improved generation mix). Forestry sales down 49% y-o-y to EUR8.3m (slightly worse than expected).

    The above led to a decline in EBITDA of 22% y-o-y to EUR30.7m (consensus at EUR30.2m), an increase of 26% from

    Q4-11. This evidences the good cash-cost performance in the quarter (cash cost at EUR338 per tonne, down 4% from

    previous quarter and -11% y-o-y. Our EUR335/t estimate, which implies an 8% annual reduction for the FY, might be

    considered conservative now).

    At the bottom line, net profit stood at EUR6.6m, also in line with the street at EUR6m.

    3 www.cheuvreux.com

  • 8/2/2019 Dayly Espaa

    4/5

    Spain TodayFriday, 27 April 2012

    Gas Natural (n/r) - Noise on a possible merger with RepsolJos Porta, Sector Head ([email protected], +34 91 495 16 71)

    A Spanish paper (5 Das) suggests La Caixa is contemplating merging Repsol and Gas Natural (La Caixa owns 13% of

    Repsol, and 35% of Gas Natural) as a way to protect Repsol from a hostile bid.

    Comment: This has been an alternative for many years, and now it resurfaces as a result of the recent expropriation of

    YPF. Our view is that it would be rather negative for Gas Natural's minorities (free float 40%), which would lose the

    attractiveness of being exposed to a gas value chain-biased story. We doubt very much that the terms of such a merger

    would be favourable to Gas Natural shareholders. Plus, the attractiveness for a utility investor in Gas Natural (with 65% of

    its EBITDA regulated) of becoming a holder of an oil company would be very limited, we believe.

    Viscofan - 3/Underperform - TP EUR34.7 (+1%) - Q1-12 results overall in lineIigo Egusquiza, Research Analyst ( , +34 91 495 16 33)[email protected]

    Q1-12 sales amounted to EUR177.9m (+13% y-o-y, slightly better than our estimate of EUR172m and consensus of

    EUR173m) as a consequence of higher volumes in the casing business (+15.1%). The geographical breakdown is thefollowing: Europe & Asia +17.7%, North America +14.5%, and LatAm +8.8%.

    Q1-12 EBITDA totalled EUR42.8m (+9.5% y-o-y, in line with our estimate of EUR43.8m and fully in line with consensus),

    with the EBITDA margin decreasing from 24.9% in Q1-11 to 24.1% in Q1-12 due to the increase in raw material and

    energy prices. The casing business also reported lower margins (from 28.2% to 26.9%).

    EBIT stood at EUR31.6m in Q1-12 (+8% y-o-y, in line with our estimate of EUR32m and fully in line with consensus) and

    net profit at EUR23.3m (+6% y-o-y, again in line with our estimate of EUR23m and consensus of EUR23.4m).

    Although we like the company and think that the strategy makes a lot of sense, we believe it is now time to start taking

    some profits as we see limited upside to our target price.

    4 www.cheuvreux.com

  • 8/2/2019 Dayly Espaa

    5/5

    Spain TodayFriday, 27 April 2012

    5 www.cheuvreux.com

    BEST REGARDS,CHEUVREUX

    Copyright Crdit Agricole Cheuvreux, 2012. All rights reserved

    All prices are those current at the end of the previous trading session unless otherwise indicated. Prices are sourced from local exchanges via ThomsonReuters or Bloomberg unless otherwise indicated. Data is sourced from CA Cheuvreuxand subject companies.This research report or summary ("Research") has been prepared by Crdit Agricole Cheuvreux or one of its affiliates or branches (collectively CA Cheuvreux) from information believed to be reliable. The opinions and projections expressed

    in this document are entirely those of CA Cheuvreux and are given as part of its normal research activity. CA Cheuvreux has not independently verified the information given in this document. Accordingly, no representation, guarantee orwarranty, express or implied, is made as to the accuracy, completeness, correctness or fairness of this information and opinions contained in this document or the research or analysis upon which such information and opinions are based. Anyopinions or estimates expressed herein reflect the judgment of CA Cheuvreux as of the date the Research was prepared and are subject to change at any time without notice. Unless otherwise stated, the information or opinions presented, orthe research or analysis upon which they are based, are updated as necessary and at least annually.Not all investment strategies are appropriate at all times, and past performance is not necessarily a guide to future performance. CA Cheuvreux recommends that independent advice should be sought, and that investors should make theirown independent decisions as to whether an investment or instrument is proper or appropriate based on their own individual judgment, their risk-tolerance, and after consulting their own investment advisers.

    CA Cheuvreux, its parent companies or its affiliates may effect transactions in the securities described herein for their own account or for the account of others, may have positions with the issuer thereof, or any of its affiliates, or may performor seek to perform securities, investment banking or other services for such issuer or its affiliates. The organisational and administrative arrangements established by CA Cheuvreux for the management of conflicts of interest with respect toinvestment research are consistent with rules, regulations or codes applicable to the securities industry. These arrangements can be found in CA Cheuvreuxs policy for managing conflicts of interest, available at www.cheuvreux.com. Currentresearch disclosures regarding companies mentioned in this Research are also available at www.cheuvreux.com.This Research is provided for information purposes only. It is not intended as an offer, invitation or solicitation to buy or sell any of the securities described or discussed herein and is intended for use only by those Professional Clients to whom

    it is made available by CA Cheuvreux. This Research is not for distribution to Retail Clients. The recipient acknowledges that, to the extent permitted by applicable securities laws and regulations, CA Cheuvreux disclaims all liability forproviding this Research, and accepts no liability whatsoever for any direct, indirect or consequential loss arising from the use of this document or its contents.CA CHEUVREUX RESEARCH AND DISTRIBUTION1. IN THE UNITED STATES, CREDIT AGRICOLE CHEUVREUX NORTH AMERICA, INC. (CAC NORTH AMERICA) SPECIFICALLY ADVISES THAT IT DID NOT PREPARE, HAS NOT CONTRIBUTED TO, HAS NOT ANALYZED, AND DOESNOT ENDORSE THIS RESEARCH. CAC North America is a SEC-registered broker-dealer, and is not an investment adviser. CAC North America does not manage assets of other entities, CAC North America does not provide investment

    advice, and CAC North America neither issues nor promulgates reports or analyses within the meaning of Section 202(a)(11) of the Investment Company Act of 1940, as amended. CAC North America is unable to provide any additionalinformation of any sort regarding this Research, and can neither support or refute any of the content, opinions, estimates, or conclusions contained in the Research. CAC North America further advises that this Research is solely intended tobe delivered to customers of CAC North America who qualify as Major U.S. institutional investors as defined in Rule 15a-6 of the Securities and Exchange Act of 1934, as amended (CAC North America Customers). CAC North America

    Customers are restricted from re-delivering the Research to any other entity, and shall be held strictly liable for any and all costs, legal fees, damages, fines, or penalties resulting from any re-delivery of the Research to persons or entities otherthan CAC North America Customers. The existence of this Research, or CAC North Americas forwarding the Research to certain of its customers, shall not be deemed a recommendation or endorsement by CAC North America of theResearch, a recommendation to effect any transactions in the securities discussed herein, or an endorsement of any opinion expressed in the Research.2. In the United Kingdom, this report is approved and/or distributed by Crdit Agricole Cheuvreux International Ltd which is authorised by the Financial Services Authority (FSA).3. In Italy, this Research is approved and/or distributed by Crdit Agricole Cheuvreux SA and is not intended for circulation or distribution either to the public at large or to any other parties other than professional clients and/or qualifiedcounterparties, as defined in Legislative Decree No.58 of 24 February 1998 as amended, and implementing Consob regulations.4. In Turkey, this document is based on information available to the public. CA Cheuvreux Menkul Degerler A.S. has spent reasonable care in verifying the accuracy and completeness of the information presented within the document and

    cannot be held responsible for any errors, omissions or for consequences arising from the use of this information. The information should not be construed, implicitly or explicitly, as constituting investment advice. This document is not an offerto buy or sell any of the securities discussed herein and has been prepared for the qualified representatives of our institutional investors.5. In Germany this report is approved and/or distributed by Crdit Agricole Cheuvreux S.A. Niederlassung Deutschland (authorised and regulated by Bundesanstalt fr Finanzdienstleistungsaufsicht (BaFin)).THE DISTRIBUTION OF THIS DOCUMENT BY CA CHEUVREUX IN OTHER JURISDICTIONS MAY BE RESTRICTED BY LAW, AND PERSONS INTO WHOSE POSSESSION THIS DOCUMENT COMES SHOULD INFORM THEMSELVES

    ABOUT, AND OBSERVE, ANY SUCH RESTRICTIONS. BY ACCEPTING THIS REPORT YOU AGREE TO BE BOUND BY THE FOREGOING INSTRUCTIONS.CLSA DISTRIBUTION1. In the United States this report is distributed by CLSA solely to persons who qualify as Major Institutional Investors (as defined in Rule 15a-6 under the U.S. Exchange Act of 1934 as may be amended from time to time) and who deal

    with Credit Agricole Corporate & Investment Bank.2. In the United Kingdom, this report is distributed by CLSA (UK) (which is authorised by the Financial Services Authority (FSA).

    3. In Australia this publication/ communication is distributed by CLSA Australia Pty Ltd;4. In Hong Kong this publication/ communication is distributed by CLSA Research Ltd;5. In India this publication/ communication is distributed by CLSA Ltd. (Address: 8/F, Dalamal House, Nairman Point, Mumbai 400021. Tel No: +91-22-66505050. SEBI Registration No: BSE Capital Market Segment: INBO10826432; BSE

    F&O Segment: INFO10826432; NSE Capital Market Segment: IN230826436; NSE F&O Segment: INF230826436);6. In Indonesia this publication/ communication is distributed by PT CLSA Indonesia;7. In Japan this publication/ communication is distributed by Credit Agricole Securities Asia B.V. Tokyo Branch, a member of the JSDA licensed to use the CLSA logo in Japan;

    8. In Korea this publication/ communication is distributed by CLSA Securities Korea Ltd;9. In Malaysia this publication/ communication is distributed by CLSA Securities Sdn Bhd;10. In the Philippines this publication/ communication is distributed by CLSA Philippines Inc. (a member of Philippine Stock Exchange and Securities Investors Protection Fund);

    11. In Thailand this publication/ communication is distributed by CLSA Securities (Thailand) Limited;12. In Taiwan this publication/ communication is distributed by CLSA Limited, Taipei Branch.13. In Singapore this publication/ communication is distributed through CLSA Singapore Pte Ltd solely to persons who qualify as Institutional, Accredited and Expert Investors only, as defined in s.4A(1) of the Securities and Futures Act,

    Pursuant to Paragraphs 33, 34, 35 and 36 of the Financial Advisers (Amendment) Regulations 2005 with regards to an Accredited Investor, Expert Investor or Overseas Investor, sections 25, 27 and 36 of the Financial Adviser Act shallnot apply to CLSA Singapore Pte Ltd. MICA (P) 168/12/2009

    THE DISTRIBUTION OF THIS DOCUMENT BY CLSA IN OTHER JURISDICTIONS MAY BE RESTRICTED BY LAW, AND PERSONS INTO WHOSE POSSESSION THIS DOCUMENT COMES SHOULD INFORM THEMSELVES ABOUT, ANDOBSERVE, ANY SUCH RESTRICTIONS. BY ACCEPTING THIS REPORT YOU AGREE TO BE BOUND BY THE FOREGOING INSTRUCTIONS.The analysts/contributors to this publication/ communication may be employed by a Credit Agricole/ CA Cheuvreux company which is different from the entity that distributes the publication/ communication in the respective jurisdictions.CLSA has not provided any contribution nor made any modifications to this publication.

    The MSCI indexes are the exclusive property of MSCI Inc. (MSCI). MSCI and the MSCI index names are service mark(s) of MSCI or its affiliates and have been licensed for use for certain purposes by CA CHEUVREUX. The financialsecurities referred to herein are not sponsored, endorsed, or promoted by MSCI, and MSCI bears no liability with respect to any such financial securities. The Prospectus contains a more detailed description of the limited relationship MSCIhas with CA CHEUVREUX and any related financial securities. No purchaser, seller or holder of this product, or any other person or entity, should use or refer to any MSCI trade name, trademark or service mark to sponsor, endorse, market orpromote this product without first contacting MSCI to determine whether MSCIs permission is required. Under no circumstances may any person or entity claim any affiliation with MSCI without the prior written permission of MSCI.The Dow Jones GCC IndexSM, or other applicable index, are calculated, distributed and marketed by Dow Jones & Company, Inc. , a licensed trademark of CME Group Index Services LLC ("CME"), and have been licensed for use. All

    content of the Dow Jones IndexesSM 2011 Dow Jones & Company, Inc.

    No part of this report may be reproduced in any manner or redistributed without the prior written permission of CA Cheuvreux.